Pérez Lloret, S., & Rascol, O. (2016). The safety and efficacy of safinamide mesylate for the treatment of Parkinson’s disease.
Citación estilo ChicagoPérez Lloret, Santiago, y Olivier Rascol. The Safety and Efficacy of Safinamide Mesylate for the Treatment of Parkinson’s Disease. 2016.
Cita MLAPérez Lloret, Santiago, y Olivier Rascol. The Safety and Efficacy of Safinamide Mesylate for the Treatment of Parkinson’s Disease. 2016.
Precaución: Estas citas no son 100% exactas.